Neuland Laboratories Quarterly Results for Trading Insights

NEULANDLAB • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹97 Cr
QSept 2025
Quarterly Results

Neuland Laboratories Quarterly Results Key Highlights

  • Revenue of ₹516 Cr in Sept 2025 (+53.6% vs Mar 2025, +63.8% vs Sept 2024)
  • Net Profit of ₹97 Cr in Sept 2025 (+246.4% vs Mar 2025, +193.9% vs Sept 2024)
  • EBITDA of ₹157 Cr in Sept 2025 (+166.1% vs Mar 2025)
  • Operating Margin of 30.0% in Sept 2025 (+14.0pp vs Mar 2025)
  • Earnings Per Share of ₹75.49 in Sept 2025 (+248.4% vs Mar 2025)

Neuland Laboratories Quarterly Results Analysis

Metric Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 QoQ YoY
Revenue (₹ Cr) 516 336 301 448 315 53.6% 63.8%
Net Profit (₹ Cr) 97 28 14 41 33 - -
EBITDA (₹ Cr) 157 59 42 85 67 - -
EPS (₹) 75.49 21.67 10.83 31.62 25.60 - -
Operating Margin (%) 30.0% 16.0% 12.0% 18.0% 20.0% - -

Neuland Laboratories Share Price Trend Around Quarterly Results

Visualize Neuland Laboratories's 1-year price movement across quarterly results — ideal for logging trades in Tickjournal. All values in ₹.

Related Pages for Neuland Laboratories

Additional stock information and data for NEULANDLAB

Neuland Laboratories share price chart
Neuland Laboratories P/E valuation
NEULANDLAB price range

Profitability Ratios

Profit Margin 18.8%
EBITDA Margin 30.4%
Operating Margin 30.0%
ROE (Annual) 25.4%

Balance Sheet Highlights

Total Assets ₹2,180 Cr
Total Equity ₹1,525 Cr
Current Assets ₹1,140 Cr
Current Liabilities ₹189 Cr

Cash Flow Analysis

Operating Cash Flow ₹317 Cr
Investing Cash Flow ₹-298 Cr
Financing Cash Flow ₹25 Cr
Net Cash Flow ₹44 Cr

Current Market Data

Current Price ₹12433.00
Exchange NSE
Last Updated Apr 02, 2026

Revenue Trend (₹ Cr)

Dec 2025 448
Jun 2025 301
Mar 2025 336
Sept 2025 516

Net Profit Trend (₹ Cr)

Dec 2025 41
Jun 2025 14
Mar 2025 28
Sept 2025 97

Operating Margin Trend (%)

Dec 2025 18.0%
Jun 2025 12.0%
Mar 2025 16.0%
Sept 2025 30.0%

Sector Competitors - Quarterly Performance Comparison

Comparing Neuland Laboratories quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹430,344.72 Cr 1693.6 14,875 3,125 +10.8% - 21.0% 130.3
Divis Laboratories
Sept 2025 		₹159,214.78 Cr 5856.5 2,860 689 +7.1% - 24.1% 225.5
Torrent Pharmaceuti…
Sept 2025 		₹144,367.29 Cr 3987.2 3,219 591 +11.3% - 18.4% 227.3
Lupin
Sept 2025 		₹107,238.09 Cr 2274.5 6,921 1,485 +23.2% - 21.5% 70.3
Dr Reddys Laborator…
Sept 2025 		₹106,974.57 Cr 1217.3 9,135 1,337 +1.1% - 14.6% 75.2
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores